查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404792

癌症诊断药物的全球市场：规模、份额和趋势分析报告 - 按产品、按类型、按应用、按最终用途、按测试类型、细分市场预测，2024-2030 年

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 240 Pages | 商品交期: 2-10个工作天内

价格

癌症诊断药物市场成长与趋势：

预计到2030年，全球癌症诊断市场规模将达到1,623.1亿美元。

预计2024年至2030年该市场将以6.16%的复合年增长率扩张。多个组织加强癌症意识提升计划是全球诊断产品需求增加的一个主要因素。国家子宫颈癌联盟、世界卫生组织、疾病预防控制中心、美国预防服务工作小组和其他机构为增加子宫颈癌筛检而建立的伙伴关係和协作是预计在预测期内推动市场成长的主要因素，也是因素之一。

因此，一些国家正在加强早期诊断筛检，并采取措施支持现有患者。例如，印度政府为在治疗期间需要援助的患者发起了「阿尤斯曼·巴拉特」和总理国家救济基金。同样，印度政府生物技术部与英国癌症研究部签署了一项协议，以研究更便宜的诊断和治疗方法。

液体活检解决方案越来越多地被采用作为 MCED 测试，因为它们易于临床应用。近年来，综合性、多癌症诊断药物方法已获得监管部门的核准。该领域的突破性进展和正在进行的早期检测研究正在促进市场成长。此外，循环肿瘤 DNA、细胞外囊泡和循环性肿瘤细胞技术正在为更好的癌症治疗铺平道路。多功能技术可以提供整合解决方案，最大限度地发挥液体活检的潜力。

使用伴同性诊断的优点是可以减少製药和诊断公司的整体时间和成本。开发和商业化新分子所需的时间通常为 10 至 15 年。诊断方法和药物的共同开发可以加快监管核准流程并大幅降低成本。自 2016 年 FDA 发布治疗和 IVD伴同性诊断开髮指南草案以来，许多製造商鼓励肿瘤学领域伴同性诊断的开发。预计这将对预测期内的市场成长产生积极影响。

癌症诊断市场报告亮点

  • 按产品划分，消耗品领域在 2023 年占据最大份额，达到 59.98%，预计在预测期内成长最快。
  • 按类型划分，体外诊断 (IVD) 领域占据主导地位，2023 年份额为 52.75%。
  • 由于在人群中传播意识的倡议不断增加以及研究和开发活动的增加，预计乳癌应用领域将在预测期内显着增长。
  • 从最终用途来看，市场以实验室领域为主，提供高效率的门诊病人服务。由于住院人数的增加，预计未来几年医院产业将显着成长。
  • 由于与测试相关的各种好处（包括疾病的早期发现），切片检查领域预计将以显着的速度增长。
  • 由于核准的新诊断测试数量不断增加，北美将在 2023 年主导全球癌症诊断市场。
  • 由于主要企业的普及和存在的增加，预计亚太地区在未来几年将显着增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 癌症发生率上升
    • 技术进步
    • 公共和私人组织加大力度
    • 广泛的研究和开发，开发新的测试解决方案
  • 市场抑制因素分析
    • 影像诊断成本高
    • 辐射暴露可能会限制电脑断层扫描的使用
    • 更多采用再生成像诊断系统
  • 营商环境分析
    • SWOT 分析：依因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章 产品经营分析

  • 癌症诊断药物市场：产品波动分析
  • 装置
    • 2018-2030年设备市场
    • 病理学设备
    • 影像设备
    • 其他的
  • 消耗品
    • 消耗品市场，2018-2030
  • 服务
    • 服务市场，2018-2030

第五章 类型业务分析

  • 癌症诊断药物市场：类型变异分析
  • IVD
    • IVD市场，2018-2030
    • IVD 市场（按类型），2018-2030 年
    • IVD 市场（按技术），2018-2030 年
  • LDT
    • LDT市场，2018-2030
  • 影像
    • 影像市场，2018-2030
    • 磁振造影(MRI)
    • 电脑断层扫描 (CT)
    • 正子断层扫描 (PET)
    • 乳房X光检查
    • 超音波
    • 其他的

第六章 应用业务分析

  • 癌症诊断药物市场：应用变化分析
  • 乳癌
    • 乳癌市场，2018-2030
  • 大肠直肠癌
    • 大肠直肠癌市场，2018-2030
  • 子宫颈癌
    • 子宫颈癌市场，2018-2030
  • 肺癌
    • 肺癌市场，2018-2030
  • 摄护腺癌
    • 摄护腺癌市场，2018-2030
  • 皮肤癌
    • 皮肤癌市场，2018-2030
  • 血癌
    • 血癌市场，2018-2030
  • 肾癌
    • 肾癌市场，2018-2030
  • 肝癌
    • 2018-2030年肝癌市场
  • 胰臟癌
    • 胰臟癌市场，2018-2030
  • 卵巢癌
    • 卵巢癌市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第七章 最终用途业务分析

  • 癌症诊断药物市场：最终用途变化分析
  • 医院
    • 医院市场，2018-2030
  • 实验室
    • 实验室市场，2018-2030
  • 其他的
    • 其他癌症诊断药物市场，2018-2030

第八章 基于检查的业务分析

  • 癌症诊断药物市场：测试类型变异分析
  • 切片检查
    • 切片检查市场，2018-2030
    • 细针抽吸
    • 核心切片检查
    • 手术切片检查
    • 皮肤切片检查/穿刺切片检查
    • 其他的
  • 其他的
    • 其他癌症诊断药物市场，2018-2030

第九章 产品经营分析

  • 癌症诊断药物市场：产品波动分析
  • 装置
    • 2018-2030年设备市场
  • 消耗品套件/试剂
    • 消耗品套件与试剂市场，2018-2030
  • 软体服务
    • 软体与服务市场，2018-2030

第10章区域业务分析

  • 癌症诊断市场占有率：按地区划分，2023 年和 2030 年
  • 北美洲
    • 2018-2030年北美癌症诊断药物市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲癌症诊断药物市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区癌症诊断市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲癌症诊断市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲癌症诊断市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十一章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导
    • 2023 年癌症诊断市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-1-68038-213-6

Cancer Diagnostics Market Growth & Trends:

The global cancer diagnostics market size is expected to reach USD 162.31 billion by 2030, as per the new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.16% from 2024 to 2030. Increasing number of programs to raise awareness about cancer by several organizations is a major factor accountable for increased demand for diagnostic products worldwide. Partnerships and collaborations undertaken by the National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, & others for increasing cervical cancer screening are among the major factors expected to boost market growth during the forecast period.

Several countries have thus undertaken measures to increase screening for early diagnosis and help existing patients. For instance, Ayushman Bharat and the Prime Minister's National Relief Fund was initiated by the Indian government for patients who require assistance during the treatment. Similarly, the Indian government's Department of Biotechnology signed a contract with Cancer Research UK to conduct research for affordable approaches to diagnosis and treatment.

Liquid biopsy solutions are being increasingly adopted as MCED tests as they are easily accessible for clinical applications. In recent years, they have gained regulatory approval with comprehensive and multi-cancer diagnostic approaches. Breakthrough advancements in the field and ongoing studies for early detection are contributing to market growth. Moreover, technologies such as circulating tumor DNA, extracellular vesicles, and circulating tumor cells are paving the way for better cancer care. Versatile technologies can provide integrated solutions for maximizing the potential of liquid biopsy.

Advantage of using companion diagnostics is the overall reduction in time and costs incurred by pharmaceutical and diagnostic companies. The time required to develop and commercialize a novel molecule generally consists of 10 to 15 years. Co-development of diagnostics and drugs facilitates accelerated regulatory approval processes, which significantly reduces costs. . Since the FDA guidance draft for the development of an IVD companion diagnostic device with a therapeutic product was published in 2016, many manufacturers encourage the development of companion diagnostic assays in the field of oncology. This is anticipated to positively impact market growth during the forecast period.

Cancer Diagnostics Market Report Highlights:

  • Based on product, the consumables segment held the largest share of 59.98% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period
  • Based on type, in vitro diagnostics (IVD) segment dominated the in 2023 with a share of 52.75% due to the increasing adoption of IVD owing to the rise in testing amid COVID-19 pandemic.
  • The breast cancer application segment is expected to grow lucratively over the forecast period due to growth in initiatives to spread awareness across the population and increase in R&D activities.
  • Based on end-use, the laboratories segment dominated the market due to efficient outpatient services. The hospitals segment is forecasted grow at a significant rate over the coming years attributed to an increase in the admittance of patients in hospitals
  • The biopsy segment is anticipated to grow at a significant growth rate due to various benefits associated with the test, including early detection of the disease
  • North America dominated the global cancer diagnostics market in 2023, owing to rise in the number of approvals of new diagnostic tests
  • The Asia Pacific is expected to grow considerably in the future owing to due to the rising prevalence and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Type Snapshot
  • 2.3. Application and End-use Snapshot
  • 2.4. Test Type Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Rising Prevalence of Cancer
    • 3.4.2. Technological Advancements
    • 3.4.3. Rising Initiatives Undertaken by Public and Private Organizations
    • 3.4.4. Extensive R&D for the Development of Novel Testing Solutions
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Diagnostic Imaging
    • 3.5.2. Radiation Exposure Likely to Limit Usage of CT Scans
    • 3.5.3. Rising Adoption of Refurbished Diagnostic Imaging Systems
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cancer Diagnostics Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Billion)
    • 4.2.2. Pathology Based-Instruments
      • 4.2.2.1. Slide Staining Systems
      • 4.2.2.1.1. Slide Staining Systems Market, 2018 - 2030 (USD Billion)
      • 4.2.2.2. Tissue Processing Systems
      • 4.2.2.2.1. Tissue Processing Systems Market, 2018 - 2030 (USD Billion)
      • 4.2.2.3. Cell Processors
      • 4.2.2.3.1. Cell Processors Systems Market, 2018 - 2030 (USD Billion)
      • 4.2.2.4. PCR Instruments
      • 4.2.2.4.1. PCR Instruments Market, 2018 - 2030 (USD Billion)
      • 4.2.2.5. NGS Instruments
      • 4.2.2.5.1. NGS Instruments Market, 2018 - 2030 (USD Billion)
      • 4.2.2.6. Microarrays
      • 4.2.2.6.1. Microarrays Market, 2018 - 2030 (USD Billion)
      • 4.2.2.7. Other Pathology-based Instruments
      • 4.2.2.7.1. Other Pathology-based Instruments Market, 2018 - 2030 (USD Billion)
    • 4.2.3. Imaging Instruments
    • 4.2.4. Others
  • 4.3. Consumables
    • 4.3.1. Consumables Market, 2018 - 2030 (USD Billion)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Billion)

Chapter 5. Type Business Analysis

  • 5.1. Cancer Diagnostics Market: Type Movement Analysis
  • 5.2. IVD
    • 5.2.1. IVD Market, 2018 - 2030 (USD Billion)
    • 5.2.2. IVD Market, By Type 2018 - 2030 (USD Billion)
      • 5.2.2.1. Diagnosis
      • 5.2.2.1.1. Diagnosis Market, 2018 - 2030 (USD Billion)
      • 5.2.2.2. Early Detection
      • 5.2.2.2.1. Early Detection Market, 2018 - 2030 (USD Billion)
      • 5.2.2.3. Therapy Selection
      • 5.2.2.3.1. Therapy Selection Market, 2018 - 2030 (USD Billion)
      • 5.2.2.4. Monitoring
      • 5.2.2.4.1. Monitoring Market, 2018 - 2030 (USD Billion)
    • 5.2.3. IVD Market, By Technology 2018 - 2030 (USD Billion)
      • 5.2.3.1. Polymerase Chain Reaction (PCR)
      • 5.2.3.1.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Billion)
      • 5.2.3.2. In Situ Hybridization (ISH)
      • 5.2.3.2.1. In Situ Hybridization (ISH) Market, 2018 - 2030 (USD Billion)
      • 5.2.3.3. Immunohistochemistry (IHC)
      • 5.2.3.3.1. Immunohistochemistry (IHC) Market, 2018 - 2030 (USD Billion)
      • 5.2.3.4. Next-generation Sequencing (NGS)
      • 5.2.3.4.1. Next-generation Sequencing (NGS) Market, 2018 - 2030 (USD Billion)
      • 5.2.3.5. Microarrays
      • 5.2.3.5.1. Microarrays Market, 2018 - 2030 (USD Billion)
      • 5.2.3.6. Flow Cytometry
      • 5.2.3.6.1. Flow Cytometry Market, 2018 - 2030 (USD Billion)
      • 5.2.3.7. Immunoassays
      • 5.2.3.7.1. Immunoassays Market, 2018 - 2030 (USD Billion)
      • 5.2.3.8. Other IVD Testing Technologies
      • 5.2.3.8.1. Other IVD Testing Technologies Market, 2018 - 2030 (USD Billion)
  • 5.3. LDT
    • 5.3.1. LDT Market, 2018 - 2030 (USD Billion)
  • 5.4. Imaging
    • 5.4.1. Imaging Market, 2018 - 2030 (USD Billion)
    • 5.4.2. Magnetic Resonance Imaging (MRI)
      • 5.4.2.1. Magnetic Resonance Imaging (MRI) Market, 2018 - 2030 (USD Billion)
    • 5.4.3. Computed Tomography (CT)
      • 5.4.3.1. Computed Tomography (CT) Market, 2018 - 2030 (USD Billion)
    • 5.4.4. Positron Emission Tomography (PET)
      • 5.4.4.1. Positron Emission Tomography (PET) Market, 2018 - 2030 (USD Billion)
    • 5.4.5. Mammography
      • 5.4.5.1. Mammography Market, 2018 - 2030 (USD Billion)
    • 5.4.6. Ultrasound
      • 5.4.6.1. Ultrasound Market, 2018 - 2030 (USD Billion)
    • 5.4.7. Others
      • 5.4.7.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Application Business Analysis

  • 6.1. Cancer Diagnostics Market: Application Movement Analysis
  • 6.2. Breast Cancer
    • 6.2.1. Breast Cancer Market, 2018 - 2030 (USD Billion)
  • 6.3. Colorectal Cancer
    • 6.3.1. Colorectal Cancer Market, 2018 - 2030 (USD Billion)
  • 6.4. Cervical Cancer
    • 6.4.1. Cervical Cancer Market, 2018 - 2030 (USD Billion)
  • 6.5. Lung Cancer
    • 6.5.1. Lung Cancer Market, 2018 - 2030 (USD Billion)
  • 6.6. Prostate Cancer
    • 6.6.1. Prostate Cancer Market, 2018 - 2030 (USD Billion)
  • 6.7. Skin Cancer
    • 6.7.1. Skin Cancer Market, 2018 - 2030 (USD Billion)
  • 6.8. Blood Cancer
    • 6.8.1. Blood Cancer Market, 2018 - 2030 (USD Billion)
  • 6.9. Kidney Cancer
    • 6.9.1. Kidney Cancer Market, 2018 - 2030 (USD Billion)
  • 6.10. Liver Cancer
    • 6.10.1. Liver Cancer Market, 2018 - 2030 (USD Billion)
  • 6.11. Pancreatic Cancer
    • 6.11.1. Pancreatic Cancer Market, 2018 - 2030 (USD Billion)
  • 6.12. Ovarian Cancer
    • 6.12.1. Ovarian Cancer Market, 2018 - 2030 (USD Billion)
  • 6.13. Others
    • 6.13.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 7. End-Use Business Analysis

  • 7.1. Cancer Diagnostics Market: End-Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2018 - 2030 (USD Billion)
  • 7.3. Laboratories
    • 7.3.1. Laboratories Market, 2018 - 2030 (USD Billion)
  • 7.4. Others
    • 7.4.1. Others Cancer Diagnostics Market, 2018 - 2030 (USD Billion)

Chapter 8. Test Type Business Analysis

  • 8.1. Cancer Diagnostics Market: Test Type Movement Analysis
  • 8.2. Biopsy
    • 8.2.1. Biopsy Market, 2018 - 2030 (USD Billion)
    • 8.2.2. Fine-needle Aspiration
      • 8.2.2.1. Fine-needle Aspiration Market, 2018 - 2030 (USD Billion)
    • 8.2.3. Core Biopsy
      • 8.2.3.1. Core Biopsy Market, 2018 - 2030 (USD Billion)
    • 8.2.4. Surgical Biopsy
      • 8.2.4.1. Surgical Biopsy Market, 2018 - 2030 (USD Billion)
    • 8.2.5. Skin Biopsy /Punch Biopsy
      • 8.2.5.1. Skin Biopsy /Punch Biopsy Market, 2018 - 2030 (USD Billion)
    • 8.2.6. Others
      • 8.2.6.1. Others Market, 2018 - 2030 (USD Billion)
  • 8.3. Others
    • 8.3.1. Others Cancer Diagnostics Market, 2018 - 2030 (USD Billion)

Chapter 9. Product Business Analysis

  • 9.1. Cancer Diagnostics Market: Product Movement Analysis
  • 9.2. Instruments
    • 9.2.1. Instruments Market, 2018 - 2030 (USD Billion)
  • 9.3. Consumables Kits and Reagents
    • 9.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Billion)
  • 9.4. Software and Services
    • 9.4.1. Software and Services Market, 2018 - 2030 (USD Billion)

Chapter 10. Regional Business Analysis

  • 10.1. Cancer Diagnostics Market Share By Region, 2023 & 2030
  • 10.2. North America
    • 10.2.1. North America Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.2.2. U.S.
      • 10.2.2.1. Key Country Dynamics
      • 10.2.2.2. Target Disease Prevalence
      • 10.2.2.3. Competitive Scenario
      • 10.2.2.4. Regulatory Framework
      • 10.2.2.5. Reimbursement Scenario
      • 10.2.2.6. U.S. Cancer diagnostics market, 2018 - 2030 (USD BILLION)
    • 10.2.3. Canada
      • 10.2.3.1. Key Country Dynamics
      • 10.2.3.2. Target Disease Prevalence
      • 10.2.3.3. Competitive Scenario
      • 10.2.3.4. Regulatory Framework
      • 10.2.3.5. Reimbursement Scenario
      • 10.2.3.6. Canada Cancer diagnostics market, 2018 - 2030 (USD Billion)
  • 10.3. Europe
    • 10.3.1. Europe Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.2. Germany
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Target Disease Prevalence
      • 10.3.2.3. Competitive Scenario
      • 10.3.2.4. Regulatory Framework
      • 10.3.2.5. Reimbursement Scenario
      • 10.3.2.6. Germany Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.3. UK
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Target Disease Prevalence
      • 10.3.3.3. Competitive Scenario
      • 10.3.3.4. Regulatory Framework
      • 10.3.3.5. Reimbursement Scenario
      • 10.3.3.6. UK Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.4. France
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Target Disease Prevalence
      • 10.3.4.3. Competitive Scenario
      • 10.3.4.4. Regulatory Framework
      • 10.3.4.5. Reimbursement Scenario
      • 10.3.4.6. France Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.5. Italy
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Target Disease Prevalence
      • 10.3.5.3. Competitive Scenario
      • 10.3.5.4. Regulatory Framework
      • 10.3.5.5. Reimbursement Scenario
      • 10.3.5.6. Italy Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.6. Spain
      • 10.3.6.1. Key Country Dynamics
      • 10.3.6.2. Target Disease Prevalence
      • 10.3.6.3. Competitive Scenario
      • 10.3.6.4. Regulatory Framework
      • 10.3.6.5. Reimbursement Scenario
      • 10.3.6.6. Spain Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.7. Denmark
      • 10.3.7.1. Key Country Dynamics
      • 10.3.7.2. Target Disease Prevalence
      • 10.3.7.3. Competitive Scenario
      • 10.3.7.4. Regulatory Framework
      • 10.3.7.5. Reimbursement Scenario
      • 10.3.7.6. Denmark Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.8. Sweden
      • 10.3.8.1. Key Country Dynamics
      • 10.3.8.2. Target Disease Prevalence
      • 10.3.8.3. Competitive Scenario
      • 10.3.8.4. Regulatory Framework
      • 10.3.8.5. Reimbursement Scenario
      • 10.3.8.6. Sweden Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.3.9. Norway
      • 10.3.9.1. Key Country Dynamics
      • 10.3.9.2. Target Disease Prevalence
      • 10.3.9.3. Competitive Scenario
      • 10.3.9.4. Regulatory Framework
      • 10.3.9.5. Reimbursement Scenario
      • 10.3.9.6. Norway Cancer diagnostics market, 2018 - 2030 (USD Billion)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.2. Japan
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Target Disease Prevalence
      • 10.4.2.3. Competitive Scenario
      • 10.4.2.4. Regulatory Framework
      • 10.4.2.5. Reimbursement Scenario
      • 10.4.2.6. Japan Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.3. China
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Target Disease Prevalence
      • 10.4.3.3. Competitive Scenario
      • 10.4.3.4. Regulatory Framework
      • 10.4.3.5. Reimbursement Scenario
      • 10.4.3.6. China Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.4. India
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Target Disease Prevalence
      • 10.4.4.3. Competitive Scenario
      • 10.4.4.4. Regulatory Framework
      • 10.4.4.5. Reimbursement Scenario
      • 10.4.4.6. India Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.5. South Korea
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Target Disease Prevalence
      • 10.4.5.3. Competitive Scenario
      • 10.4.5.4. Regulatory Framework
      • 10.4.5.5. Reimbursement Scenario
      • 10.4.5.6. South Korea Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.6. Australia
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Target Disease Prevalence
      • 10.4.6.3. Competitive Scenario
      • 10.4.6.4. Regulatory Framework
      • 10.4.6.5. Reimbursement Scenario
      • 10.4.6.6. Australia Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.4.7. Thailand
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Target Disease Prevalence
      • 10.4.7.3. Competitive Scenario
      • 10.4.7.4. Regulatory Framework
      • 10.4.7.5. Reimbursement Scenario
      • 10.4.7.6. Thailand Cancer diagnostics market, 2018 - 2030 (USD Billion)
  • 10.5. Latin America
    • 10.5.1. Latin America Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.5.2. Brazil
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Target Disease Prevalence
      • 10.5.2.3. Competitive Scenario
      • 10.5.2.4. Regulatory Framework
      • 10.5.2.5. Reimbursement Scenario
      • 10.5.2.6. Brazil Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.5.3. Mexico
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Target Disease Prevalence
      • 10.5.3.3. Competitive Scenario
      • 10.5.3.4. Regulatory Framework
      • 10.5.3.5. Reimbursement Scenario
      • 10.5.3.6. Mexico Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.5.4. Argentina
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Target Disease Prevalence
      • 10.5.4.3. Competitive Scenario
      • 10.5.4.4. Regulatory Framework
      • 10.5.4.5. Reimbursement Scenario
      • 10.5.4.6. Argentina Cancer diagnostics market, 2018 - 2030 (USD Billion)
  • 10.6. MEA
    • 10.6.1. MEA Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.6.2. South Africa
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Target Disease Prevalence
      • 10.6.2.3. Competitive Scenario
      • 10.6.2.4. Regulatory Framework
      • 10.6.2.5. Reimbursement Scenario
      • 10.6.2.6. South Africa Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.6.3. Saudi Arabia
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Target Disease Prevalence
      • 10.6.3.3. Competitive Scenario
      • 10.6.3.4. Regulatory Framework
      • 10.6.3.5. Reimbursement Scenario
      • 10.6.3.6. Saudi Arabia Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.6.4. UAE
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Target Disease Prevalence
      • 10.6.4.3. Competitive Scenario
      • 10.6.4.4. Regulatory Framework
      • 10.6.4.5. Reimbursement Scenario
      • 10.6.4.6. UAE Cancer diagnostics market, 2018 - 2030 (USD Billion)
    • 10.6.5. Kuwait
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Target Disease Prevalence
      • 10.6.5.3. Competitive Scenario
      • 10.6.5.4. Regulatory Framework
      • 10.6.5.5. Reimbursement Scenario
      • 10.6.5.6. Kuwait Cancer diagnostics market, 2018 - 2030 (USD Billion)

Chapter 11. Competitive Landscape

  • 11.1. Participant's overview
  • 11.2. Financial performance
  • 11.3. Participant categorization
    • 11.3.1. Market Leaders
    • 11.3.2. Cancer Diagnostics Market Share Analysis, 2023
    • 11.3.3. Company Profiles
      • 11.3.3.1. ABBOTT
      • 11.3.3.1.1. Company Overview
      • 11.3.3.1.2. Financial Performance
      • 11.3.3.1.3. Product Benchmarking
      • 11.3.3.1.4. Strategic Initiatives
      • 11.3.3.2. GE HEALTHCARE
      • 11.3.3.2.1. Company Overview
      • 11.3.3.2.2. Financial Performance
      • 11.3.3.2.3. Product Benchmarking
      • 11.3.3.2.4. Strategic Initiatives
      • 11.3.3.3. F. HOFFMANN-LA ROCHE LTD.
      • 11.3.3.3.1. Company Overview
      • 11.3.3.3.2. Financial Performance
      • 11.3.3.3.3. Product Benchmarking
      • 11.3.3.3.4. Strategic Initiatives
      • 11.3.3.4. QIAGEN
      • 11.3.3.4.1. Company Overview
      • 11.3.3.4.2. Financial Performance
      • 11.3.3.4.3. Product Benchmarking
      • 11.3.3.4.4. Strategic Initiatives
      • 11.3.3.5. BD
      • 11.3.3.5.1. Company Overview
      • 11.3.3.5.2. Financial Performance
      • 11.3.3.5.3. Product Benchmarking
      • 11.3.3.5.4. Strategic Initiatives
      • 11.3.3.6. SIEMENS HEALTHCARE GMBH
      • 11.3.3.6.1. Company Overview
      • 11.3.3.6.2. Financial Performance
      • 11.3.3.6.3. Product Benchmarking
      • 11.3.3.6.4. Strategic Initiatives
      • 11.3.3.7. THERMO FISHER SCIENTIFIC, INC.
      • 11.3.3.7.1. Company Overview
      • 11.3.3.7.2. Financial Performance
      • 11.3.3.7.3. Product Benchmarking
      • 11.3.3.7.4. Strategic Initiatives
      • 11.3.3.8. HOLOGIC, INC.
      • 11.3.3.8.1. Company Overview
      • 11.3.3.8.2. Financial Performance
      • 11.3.3.8.3. Product Benchmarking
      • 11.3.3.8.4. Strategic Initiatives
      • 11.3.3.9. KONINKLIJKE PHILIPS N.V. (PHILIPS)
      • 11.3.3.9.1. Company Overview
      • 11.3.3.9.2. Financial Performance
      • 11.3.3.9.3. Product Benchmarking
      • 11.3.3.9.4. Strategic Initiatives
      • 11.3.3.10. ILLUMINA, INC.
      • 11.3.3.10.1. Company Overview
      • 11.3.3.10.2. Financial Performance
      • 11.3.3.10.3. Product Benchmarking
      • 11.3.3.10.4. Strategic Initiatives
    • 11.3.4. Strategy Mapping
      • 11.3.4.1. Expansion
      • 11.3.4.2. Acquisition
      • 11.3.4.3. Collaborations
      • 11.3.4.4. Disease Type/Drug Class Launch
      • 11.3.4.5. Partnerships
      • 11.3.4.6. Others

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global cancer diagnostics market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Global cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Global cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 8 North America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 9 North America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 10 North America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 11 North America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 12 North America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 13 North America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 14 U.S. cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 15 U.S. cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 16 U.S. cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 17 U.S. cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 U.S. cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 19 Canada cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 20 Canada cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Canada cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 22 Canada cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 23 Canada cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 24 Europe cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 26 Europe cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Europe cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Europe cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 Europe cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 30 UK cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 31 UK cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 32 UK cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 33 UK cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 34 UK cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 35 Germany cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 36 Germany cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 37 Germany cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 38 Germany cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Germany cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 40 France cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 41 France cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 42 France cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 43 France cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44 France cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 45 Italy cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Italy cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Italy cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Italy cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Italy cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 50 Spain cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 51 Spain cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 52 Spain cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 53 Spain cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 54 Spain cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 55 Denmark cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 56 Denmark cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 57 Denmark cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 58 Denmark cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 Denmark cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 60 Sweden cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 61 Sweden cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Sweden cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 63 Sweden cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 Sweden cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 65 Norway cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 66 Norway cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 67 Norway cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 68 Norway cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 69 Norway cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 76 Japan cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 77 Japan cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 78 Japan cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 79 Japan cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 Japan cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 81 China cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 82 China cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 83 China cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 84 China cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 85 China cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 86 India cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 87 India cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 88 India cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 89 India cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 India cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 91 South Korea cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 92 South Korea cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 93 South Korea cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 94 South Korea cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 95 South Korea cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 96 Thailand cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 97 Thailand cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 98 Thailand cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 99 Thailand cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 100 Thailand cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 101 Australia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 102 Australia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 103 Australia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 104 Australia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 105 Australia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 106 Latin America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 107 Latin America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 108 Latin America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 109 Latin America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 110 Latin America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 111 Latin America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 112 Brazil cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 113 Brazil cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 114 Brazil cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 115 Brazil cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 116 Brazil cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 117 Mexico cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 118 Mexico cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 119 Mexico cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 120 Mexico cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 121 Mexico cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 122 Argentina cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 123 Argentina cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 124 Argentina cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 125 Argentina cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 126 Argentina cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 127 Middle East & Africa cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 128 Middle East & Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 129 Middle East & Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 130 Middle East & Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 131 Middle East & Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 132 Middle East & Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 133 South Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 134 South Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 135 South Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 136 South Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 137 South Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 138 Saudi Arabia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 139 Saudi Arabia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 140 Saudi Arabia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 141 Saudi Arabia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 142 Saudi Arabia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 143 UAE cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 144 UAE cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 145 UAE cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 146 UAE cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 147 UAE cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
  • Table 148 Kuwait cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
  • Table 149 Kuwait cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
  • Table 150 Kuwait cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 151 Kuwait cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 152 Kuwait cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Cancer diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Product and type segment snapshot
  • Fig. 11 Application segment snapshot
  • Fig. 12 End-use and test type segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Cancer diagnostics market value, 2023 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 Incidence of most common cancers globally, 2020
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTLE analysis
  • Fig. 19 Cancer diagnostics market: Product outlook and key takeaways
  • Fig. 20 Cancer diagnostics market: Product movement analysis
  • Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Slide staining systems market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Tissue processing systems market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Cell processors market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 PCR instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 NGS instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Other pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Imaging instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Consumables market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Probes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 Cancer diagnostics market: Type outlook and key takeaways
  • Fig. 39 Cancer diagnostics market: Type movement analysis
  • Fig. 40 IVD market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Diagnosis market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Early detection market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Therapy selection market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Monitoring market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 In Situ Hybridization (ISH) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Immunohistochemistry (IHC) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Next-generation Sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Immunoassays market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 Other IVD testing technologies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 LDT market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Imaging market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Computed Tomography (CT) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Positron Emission Tomography (PET) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Mammography market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Ultrasound market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Cancer diagnostics market: Application outlook and key takeaways
  • Fig. 62 Cancer diagnostics market: Application movement analysis
  • Fig. 63 Breast cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 Cervical cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Lung cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 67 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 68 Skin cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 69 Blood cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 70 Kidney cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 71 Liver cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Pancreatic cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Ovarian cancer market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 75 Cancer diagnostics market: End-use outlook and key takeaways
  • Fig. 76 Cancer diagnostics market: End-use movement analysis
  • Fig. 77 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 78 Laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 79 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 80 Cancer diagnostics market: Test type outlook and key takeaways
  • Fig. 81 Cancer diagnostics market: Test type movement analysis
  • Fig. 82 Biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 83 Fine-needle aspiration market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 84 Core biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 85 Surgical biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 86 Skin biopsy/punch biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 87 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 88 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 89 Cancer Diagnostics Market revenue, by region, 2023 & 2030 (USD Billion)
  • Fig. 90 Regional marketplace: Key takeaways
  • Fig. 91 Regional marketplace: Key takeaways
  • Fig. 92 North America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 U.S. cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 95 Cancer incidence, 2018-2030
  • Fig. 96 Ways to obtain coverage
  • Fig. 97 Key country dynamics
  • Fig. 98 Canada cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 99 Cancer incidence, 2018-2030
  • Fig. 100 Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 101 Key country dynamics
  • Fig. 102 UK cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 103 Cancer incidence, 2018-2030
  • Fig. 104 Key country dynamics
  • Fig. 105 Germany cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 106 Cancer incidence, 2018-2030
  • Fig. 107 Key country dynamics
  • Fig. 108 France cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 109 Cancer incidence, 2018-2030
  • Fig. 110 Key country dynamics
  • Fig. 111 Spain cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 112 Cancer incidence, 2018-2030
  • Fig. 113 Key country dynamics
  • Fig. 114 Italy cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 115 Cancer incidence, 2018-2030
  • Fig. 116 Key country dynamics
  • Fig. 117 Denmark cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 118 Target disease prevalence
  • Fig. 119 Key country dynamics
  • Fig. 120 Sweden cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 121 Five most common cancers in Sweden
  • Fig. 122 Key country dynamics
  • Fig. 123 Norway cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 124 Number of new cancer cases in 2020, both sexes, all ages
  • Fig. 125 Rest of Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 126 Asia Pacific cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 127 Key country dynamics
  • Fig. 128 Japan cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 129 Cancer incidence, 2018 to 2030
  • Fig. 130 Key country dynamics
  • Fig. 131 China cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 132 Cancer incidence, 2018 to 2030
  • Fig. 133 China regulatory details
  • Fig. 134 Key country dynamics
  • Fig. 135 India cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 136 Cancer incidence, 2018 to 2030
  • Fig. 137 Key country dynamics
  • Fig. 138 Australia cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 139 Cancer incidence, 2018 to 2030
  • Fig. 140 Key country dynamics
  • Fig. 141 Thailand cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 142 Cancer incidence, 2020 to 2030
  • Fig. 143 Key country dynamics
  • Fig. 144 South Korea cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 145 Cancer incidence 2018 to 2030
  • Fig. 146 South Korean regulations in four hierarchical orders
  • Fig. 147 South Korea reimbursement scenario
  • Fig. 148 Rest of Asia Pacific cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 149 Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 150 Key country dynamics
  • Fig. 151 Brazil cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 152 Estimated number of new cancer cases in Brazil
  • Fig. 153 Key country dynamics
  • Fig. 154 Mexico cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 155 Estimated number of new cancer cases in Mexico
  • Fig. 156 Key country dynamics
  • Fig. 157 Argentina cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 158 Estimated number of new cancer cases in Argentina
  • Fig. 159 Rest of Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 160 MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 161 Key country dynamics
  • Fig. 162 South Africa cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 163 Cancer prevalence-2018-2030
  • Fig. 164 Key country dynamics
  • Fig. 165 Saudi Arabia cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 166 Cancer prevalence-2018-2030
  • Fig. 167 Key country dynamics
  • Fig. 168 UAE cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 169 Cancer prevalence 2018-2030
  • Fig. 170 Key country dynamics
  • Fig. 171 Kuwait cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 172 Target disease prevalence
  • Fig. 173 Key payers in Kuwait
  • Fig. 174 Rest of MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 175 Key company categorization
  • Fig. 176 Company market share analysis, 2023
  • Fig. 177 Strategic framework